Research & Development
Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's Disease at Alzheimer's Disease Annual Meeting to be held from March 28, 2023 to April 1 in Gothenburg, Sweden, " AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases "
Session | Subject | Presenter (Affiliation) |
Oral:
SYMPOSIUM:
FLUID BIOMARKERS, IMAGING (OO095) |
Effects of combined pre-analytical sample handling variables on plasma β-amyloid level measured using a fully automated immunoassay system.
|
Kazuto Yamashita (SYSMEX) |
ON-DEMAND
SYMPOSIUM:
FLUID BIOMARKERS 03 (OD322)*
|
Development of plasma p-tau231 assay on a fully automated immunoassay system.
|
Kengo Ishiki (SYSMEX) |
Terminology | ||
* | Joint announcement with Sysmex Corporation, Sysmex R&D Center Americas and ADx NeuroSciences | |